Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases.
暂无分享,去创建一个
N Hanai | J. Marth | A. Peterson | D. Leclerc | N. Hanai | J. Trasler | N. Wakamatsu | C. Morales | R. Gravel | A. Borowski | D. Phaneuf | B. Akerman | J D Marth | Suleiman A. Igdoura | D Phaneuf | N Wakamatsu | J Q Huang | A Borowski | A C Peterson | S R Fortunato | G Ritter | S A Igdoura | C R Morales | G Benoit | B R Akerman | D Leclerc | J M Trasler | R A Gravel | J. Q. Huang | S. Fortunato | G. Ritter | G. Benoit
[1] Michael P. McDonald,et al. Mouse models of Tay–Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism , 1995, Nature Genetics.
[2] E. Snyder,et al. Neural progenitor cell engraftment corrects lysosomal storage throughout the MRS VII mouse brain , 1995, Nature.
[3] L. Riboni,et al. The Degradative Pathway of Gangliosides GM1 and GM2 in Neuro2a Cells by Sialidase , 1995, Journal of neurochemistry.
[4] A. Lamhonwah,et al. Structural organization, sequence, and expression of the mouse HEXA gene encoding the alpha subunit of hexosaminidase A. , 1994, Genomics.
[5] J. Trasler,et al. Characterization of the murine -hexosaminidase (HEXB) gene , 1994 .
[6] J. Månsson,et al. Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord. , 1994, Biochimica et biophysica acta.
[7] K Suzuki,et al. Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[8] E. Neuwelt,et al. Characterization of the molecular defect in a feline model for type II GM2-gangliosidosis (Sandhoff disease). , 1994, The American journal of pathology.
[9] K. Shitara,et al. Chimeric anti-ganglioside GM2 antibody with antitumor activity. , 1994, Cancer research.
[10] J. Roder,et al. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[11] J L Stirling,et al. Cloning and sequence analysis of a cDNA encoding the alpha-subunit of mouse beta-N-acetylhexosaminidase and comparison with the human enzyme. , 1992, The Biochemical journal.
[12] R. Hawkes,et al. The modular cerebellum , 1991, Progress in Neurobiology.
[13] H. J. Baker,et al. Neuroaxonal dystrophy in neuronal storage disorders: Evidence for major GABAergic neuron involvement , 1991, Journal of the Neurological Sciences.
[14] Allan Bradley,et al. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice , 1991, Cell.
[15] G. Brewer,et al. Gangliosides and synaptic transmission. , 1990, Biochimica et biophysica acta.
[16] S. Tsuiki,et al. Biochemical and immunological studies on two distinct ganglioside-hydrolyzing sialidases from the particulate fraction of rat brain. , 1990, Journal of biochemistry.
[17] D. Mahuran. Characterization of human placental beta-hexosaminidase I2. Proteolytic processing intermediates of hexosaminidase A. , 1990, The Journal of biological chemistry.
[18] H. J. Baker,et al. Initiation and growth of ectopic neurites and meganeurites during postnatal cortical development in ganglioside storage disease. , 1990, Brain research. Developmental brain research.
[19] C. Schengrund. The role(s) of Gangliosides in neural differentiation and repair: A perspective , 1990, Brain Research Bulletin.
[20] H. Yamada,et al. Characterization of mouse liver sialidase and partial purification of the lysosomal sialidase. , 1988, Chemical and pharmaceutical bulletin.
[21] D. Mahuran,et al. Cloning and sequence analysis of a cDNA encoding the β‐subunit of mouse β‐hexosaminidase , 1988 .
[22] T. Beccari,et al. Identification of beta-N-acetylhexosaminidase A in mouse tissues with the fluorigenic substrate 4-methylumbelliferyl-beta-N-acetylglucosamine 6-sulphate. , 1988, The Biochemical journal.
[23] R. Geyer,et al. Glycosphingolipid composition of human semen. , 1987, Archives of biochemistry and biophysics.
[24] H. Willard,et al. Molecular heterogeneity in the infantile and juvenile forms of Sandhoff disease (O-variant GM2 gangliosidosis). , 1986, The Journal of biological chemistry.
[25] J. Stirling,et al. Purification and characterization of beta-N-acetylhexosaminidase I2 from human liver. , 1986, Biochemical Journal.
[26] R. Ledeen. Gangliosides of the neuron , 1985, Trends in Neurosciences.
[27] W. Johnson,et al. Characterization of a new model of GM2-gangliosidosis (Sandhoff's disease) in Korat cats. , 1985, The Journal of clinical investigation.
[28] K. Sandhoff,et al. Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A. , 1985, The Journal of biological chemistry.
[29] H. Rösner,et al. Topographical Atlas of the Gangliosides of the Adult Human Brain , 1984, Journal of neurochemistry.
[30] K. Sandhoff,et al. Activating proteins for ganglioside GM2 degradation by beta-hexosaminidase isoenzymes in tissue extracts from different species. , 1983, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[31] N. Kin,et al. Deficiency of the Hexosaminidase A Activator Protein in a Case of GM2 Gangliosidosis; Variant AB , 1982, Pediatric Research.
[32] S. Kosanke,et al. Clinical and Biochemical Abnormalities in Porcine GM2-Gangliosidosis , 1978, Veterinary pathology.
[33] K. Sandhoff,et al. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[34] R. Arnon,et al. Immunochemical and biochemical investigation of hexosaminidase S. , 1977, American journal of human genetics.
[35] H. J. Baker,et al. GM2 ganglioside lysosomal storage disease in cats with beta-hexosaminidase deficiency. , 1977, Science.
[36] K. Sandhoff,et al. ENZYME ALTERATIONS AND LIPID STORAGE IN THREE VARIANTS OF TAY‐SACHS DISEASE , 1971, Journal of neurochemistry.
[37] E. Karbe,et al. Familial Amaurotic Idiocy in Male German Shorthair Pointers , 1967, Pathologia veterinaria.
[38] J. Trasler,et al. Characterization of the murine beta-hexosaminidase (HEXB) gene. , 1994, Biochimica et Biophysica Acta.
[39] A. Joyner,et al. Production of targeted embryonic stem cell clones. , 1993 .
[40] A. Joyner,et al. Production of chimeras and genetically defined offspring from targeted ES cells. , 1993 .
[41] Alexandra L. Joyner,et al. Gene targeting: a practical approach. , 1993 .
[42] D. Mahuran,et al. Cloning and sequence analysis of a cDNA encoding the beta-subunit of mouse beta-hexosaminidase. , 1988, FEBS Letters.
[43] K. Suzuki. Enzymatic diagnosis of sphingolipidoses. , 1987, Methods in enzymology.
[44] L. Svennerholm. Gangliosides and synaptic transmission. , 1980, Advances in experimental medicine and biology.
[45] T. Momoi,et al. Separation and micro-detection of oligosaccharides of glycosphingolipids by high performance cellulose thin-layer chromatography-autoradiofluorography. , 1980, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[46] P. Mandel,et al. Structure and Function of Gangliosides , 1980, Advances in Experimental Medicine and Biology.
[47] K. Sandhoff,et al. Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A. , 1979, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[48] M. Adachi,et al. Ultrastructural studies of eight cases of fetal Tay-Sachs disease. , 1974, Laboratory investigation; a journal of technical methods and pathology.